STOCK TITAN

Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Bristol Myers Squibb (NYSE: BMY) has announced its upcoming participation at J.P. Morgan's 43rd Annual Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, beginning at 7:30 a.m. PT/10:30 a.m. ET.

The event will feature a company presentation and fireside chat, which will be accessible through a simultaneous webcast at investor.bms.com. Presentation materials will be made available at the start of the live webcast. Following the event's conclusion, both a replay and archived version of the presentation will be accessible to viewers.

Bristol Myers Squibb (NYSE: BMY) ha annunciato la sua prossima partecipazione alla 43ª Conferenza Annuale sulla Salute di J.P. Morgan. La presentazione è programmata per lunedì 13 gennaio 2025, con inizio alle 7:30 a.m. PT/10:30 a.m. ET.

L'evento includerà una presentazione dell'azienda e una chiacchierata informale, che sarà accessibile attraverso una trasmissione in diretta sul sito investor.bms.com. I materiali della presentazione saranno disponibili all'inizio della trasmissione in diretta. Dopo la conclusione dell'evento, sarà possibile accedere sia a una replica che a una versione archiviata della presentazione.

Bristol Myers Squibb (NYSE: BMY) ha anunciado su próxima participación en la 43ª Conferencia Anual de Salud de J.P. Morgan. La presentación está programada para el lunes 13 de enero de 2025, comenzando a las 7:30 a.m. PT/10:30 a.m. ET.

El evento contará con una presentación de la empresa y una charla informal, que será accesible a través de una transmisión simultánea en investor.bms.com. Los materiales de la presentación estarán disponibles al inicio de la transmisión en vivo. Después de la conclusión del evento, tanto la repetición como una versión archivada de la presentación estarán accesibles para los espectadores.

브리스톨 마이어스 스큅 (NYSE: BMY)JP 모건의 제43회 연례 의료 회의에 참석할 예정이라고 발표했습니다. 발표는 2025년 1월 13일 월요일 오전 7:30 PT/10:30 ET에 시작됩니다.

이번 행사에서는 기업 발표와 불꽃놀이 대화가 포함되며, investor.bms.com에서 동시에 웹캐스트를 통해 접근할 수 있습니다. 발표 자료는 라이브 웹캐스트 시작 시 제공될 예정입니다. 행사가 종료된 후에는 발표의 재생 및 아카이브 버전이 시청자에게 제공됩니다.

Bristol Myers Squibb (NYSE: BMY) a annoncé sa prochaine participation à la 43ème Conférence Annuelle sur la Santé de J.P. Morgan. La présentation est prévue pour le lundi 13 janvier 2025, à partir de 7h30 PT/10h30 ET.

L'événement comprendra une présentation de l'entreprise et une discussion informelle, qui sera accessible via un webinaire simultané sur investor.bms.com. Les documents de présentation seront disponibles au début du webinaire en direct. Après la conclusion de l'événement, une rediffusion ainsi qu'une version archive de la présentation seront accessibles aux spectateurs.

Bristol Myers Squibb (NYSE: BMY) hat seine bevorstehende Teilnahme an der 43. jährlichen Gesundheitskonferenz von J.P. Morgan bekannt gegeben. Die Präsentation ist für Montag, den 13. Januar 2025 geplant und beginnt um 7:30 Uhr PT/10:30 Uhr ET.

Die Veranstaltung wird eine Unternehmenspräsentation und ein informelles Gespräch umfassen, die über einen simultanen Webcast auf investor.bms.com zugänglich sein werden. Präsentationsmaterialien werden zu Beginn des Live-Webcasts verfügbar sein. Nach Abschluss der Veranstaltung wird sowohl eine Wiederholung als auch eine archivierte Version der Präsentation für die Zuschauer zugänglich sein.

Positive
  • None.
Negative
  • None.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 43rd Annual Healthcare Conference on Monday, January 13, 2025.

The company’s presentation and participation in a fireside chat will begin at 7:30 a.m. PT/10:30 a.m. ET.

The event will be webcast simultaneously at http://investor.bms.com, with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the conclusion of the event.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram.

corporatefinancial-news

Media:

media@bms.com



Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When is Bristol Myers Squibb (BMY) presenting at the JP Morgan Healthcare Conference 2025?

Bristol Myers Squibb will present at JP Morgan's Healthcare Conference on Monday, January 13, 2025, at 7:30 a.m. PT/10:30 a.m. ET.

How can investors watch BMY's presentation at the 2025 JP Morgan Healthcare Conference?

Investors can watch the presentation through a live webcast at investor.bms.com. A replay and archived version will be available after the event.

What type of presentation will BMY deliver at the 2025 JP Morgan Healthcare Conference?

BMY will deliver a company presentation and participate in a fireside chat at the conference.

Will BMY's presentation materials from the JP Morgan Healthcare Conference be publicly available?

Yes, presentation materials will be available at investor.bms.com at the start of the live webcast.

Bristol-Myers Squibb Co.

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Stock Data

113.92B
2.03B
0.12%
78.54%
1.36%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
PRINCETON